May 22, 2024 / 12:30PM GMT
Operator
Ladies and gentlemen, good day, and welcome to Gland Pharma Limited Q4 and FY24 earnings conference call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Ankit. Thank you and over to you, sir.
Ankit Gupta - Gland Pharma Ltd - Vice President- Strategy and Investments
Thank you, Nirap. Good evening, everyone, and we welcome you to Gland Pharma earnings conference call for Q4 and FY24. My name is Ankit and I head Investment, M&A, and Corporate Strategy at Gland. Joining me today are Mr. Srinivas Sadu, our MD and CEO; Mr. Ravi Mitra, our CFO; and we also have today Mr. Alain, the CEO of Cenexi, our European CDMO business. Together today, we'll discuss our business performance and address any questions that you may have.
We will begin with the business highlights on Gland and Cenexi from Mr. Sadu, followed by an overview on Cenexi and the turnaround strategy from Mr. Alain, and lastly, the group financial review by Mr. Ravi. Before we proceed, I'd like to remind everyone that some of the
Q4 2024 Gland Pharma Ltd Earnings Call Transcript
May 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers